|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
Blood, 15 August 2007, Vol. 110, No. 4, pp. 1086-1087.
The STATus of miR-21 in apoptosisNATIONAL CANCER INSTITUTE
In this issue of Blood, Löffler and colleagues report the regulation of microRNA-21 by IL-6, through a Stat3-dependent mechanism, which results in the repression of apoptosis in multiple myeloma cells.
The IL-6 pathway, through Stat3 activation, is an important pathway for many carcinomas, including both multiple myeloma and prostate cancer (reviewed by Hodge et al3). Stat3 coordinates the expression of many genes, including several antiapoptotic proteins. The transcriptional regulation of these genes contributes to the survival of cancer cells, but it has been recently demonstrated that there is a second independent survival pathway linked to Stat3 activation.4 The report by Löffler and colleagues defines a regulatory pathway beginning with an exogenous signal and culminating in the up-regulation of an miRNA, resulting in the inhibition of apoptosis. Using an informatics approach, they identify 2 phylogenetically conserved STAT3 binding sites in the upstream region of microRNA-21 (miR-21). Through a chromatin immunoprecipitation (ChIP) assay, they demonstrate the binding of Stat3 to an upstream enhancer following IL-6 treatment of multiple myeloma cell lines. They further show that either mutation of the Stat3 binding sites in the enhancer of miR-21 or the siRNA knockdown of Stat3 abrogates induction of miR-21 by IL-6. Moreover, ectopic miR-21 expression is sufficient to sustain growth of IL-6-dependent cell lines in the absence of IL-6. This represents one of the first descriptions of miRNA regulation in humans and identifies miR-21 as an important regulator of cancer-cell survival. How does miR-21 expression result in an antiapoptotic signal? Although Löffler and colleagues do not explore this, tropomyosin 1 (TPM1), a tumor suppressor gene, was recently identified as a target for miR-21 in breast cancer cells.5 Although TPM1, which associates with actin and stabilizes microfilament structures, provides an attractive model for the ability of miR-21 expression to contribute to breast cancer etiology, mirRNAs have multiple predicted targets. Indeed, Zhu et al5 identified many proteins regulated by miR-21 and therefore the exact mechanism of how miR-21 inhibits apoptosis and/or promotes proliferation warrants further investigation. Nevertheless, in describing the regulation of miR-21, Löffler and colleagues have defined an additional mechanism of how IL-6 represses apoptosis of multiple meyloma, thereby expanding the list of potential therapeutic targets (see figure).
Footnotes
Conflict-of-interest disclosure: This publication has been funded in part with Federal funds from the National Cancer Institute, National Institutes of Health, under contract No. N01-CO-12400. This research was supported in part by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute.
The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.
REFERENCES
  CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
 |
 |
|||||||||
 |
 |
 |
 |
 |
 |
 |
 |
||||
| |||||||||||
| Copyright © 2007 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||||
